Crenolanib is a n orally bioavailable small molecule, targeting the platelet-derived growth factor receptor (PDGFR), with potential antineoplastic activity.
For research use only. We do not sell to patients.
Chemical Information
Name Crenolanib
Iupac Chemical Name 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine
Synonyms CP-868596; CP 868596; CP868596
Molecular Formula C26H29N5O2
Molecular Weight 443.541
Smile NC1CCN(C2=C3N=C(N4C=NC5=CC(OCC6(C)COC6)=CC=C45)C=CC3=CC=C2)CC1
InChiKey DYNHJHQFHQTFTP-UHFFFAOYSA-N
InChi InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3
CAS Number 670220-88-9
Related CAS
Ordering Information
Packaging Price Availability Purity Shipping Time
Bulk Enquiry Enquiry Enquiry
Formulation Solid powder
Purity 98%
Storage -20 ºC for 3 years
Solubility Soluble in DMSO
Handling
Shipping Condition Shipped under ambient temperature
HS Code
Targets
Mechanism
Cell study
Animal study
Clinical study